A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

March 24, 2008

Group Psychotherapy Improves Mood, but Not Adherence

A 12-week course of specialized psychological group counseling improved mood and quality of life in people living with HIV, but did not improve CD4 count, viral load or adherence to antiretroviral therapy, according to a study published in the March 30 issue of AIDS.

Simona Berger, from the Institute of Psychology at the University of Zurich in Switzerland, and her colleagues set out to determine whether cognitive behavioral stress management (CBSM)—which seeks to change a person’s negative and self-defeating thinking and behavior to improve their mood and functional ability—could enhance people’s physical health and adherence to HIV treatment, as well as their mood and quality of life.

A number of studies using individual- and group-based cognitive behavioral strategies have found that they can improve adherence to treatment in HIV and other diseases. Also, several studies published before the introduction of potent antiretroviral combination therapy in 1996 found that cognitive behavioral therapy could positively impact CD4 counts and the stress hormone cortisol.

Berger’s team enrolled and randomized 104 people living with HIV from the Swiss HIV Cohort Study to receive either a 12-week CBSM group therapy course or no intervention. Participants needed to be on stable antiretroviral therapy and have CD4 counts over 100. The study subjects also needed to be free of any major psychiatric disorders, and could not have received psychological counseling for at least three months before enrolling in the study. The participants completed surveys of their mood and quality of life—determined by measuring physical and psychological symptoms of HIV disease and treatment—at regular intervals for one year after entering the study. CD4 counts, viral load and adherence to HIV treatment were also assessed.

Berger’s group found that the CBSM intervention had no impact on participants’ viral load, CD4 count or adherence to antiretroviral therapy during any point of the study. However, it did improve mood and their quality of life, with sustained improvements for approximately eight months after completing the intervention. People receiving no intervention did not experience these improvements, and the difference between the group receiving CBSM and the group receiving no intervention was statistically significant, meaning that the difference was too large to have occurred by chance. The degree of improvement was especially large in the CBSM participants who entered the study with higher levels of depression and anxiety.

Berger’s team suggests that the lack of effect on CD4 counts or viral load in this study may be a result of the fact that psychological factors have little impact on clinical well-being in a general population of people living with HIV who are on effective antiretrovirals. The team hypothesizes, however, that a clinical benefit and improvements in adherence might be seen if health care providers limit psychological interventions to people with higher levels of depression and anxiety.

It should be noted that some studies of both group and individual interventions designed to improve people’s knowledge, encourage positive thinking, and decrease depression and anxiety have found improvements in adherence when these interventions were targeted to people with mood disorders and adherence problems.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Greg747, Patchogue, NY, 2008-03-26 11:29:41
This research bolsters my point that the re-tooled Ryan White Act of '06 was a disaster to PWAs. Mandating 'clinical medical indicators' for program outcomes (to receive federal funding) was and is wrong. I will repeat the refrain, again, we PWAs are more than just presciptions! We need food, shelter, warmth, and counselling services to live.

Nikki, philadelphia, 2008-03-25 16:23:32
I have never had a problem w/adherence. I avoid group because member seemed to get off the subject and discuss everything but issues they need to discuss. Often the member come for the food, take cell phone calls, play their CD walkman, discuss fashion etc. I feel better meditating at home among other things

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    fern_09
    Atlanta
    Georgia


    sevane
    Los Angeles
    California


    leanmscllatin
    Los Angeles
    California


    jonhart48
    Stamford
    Connecticut
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.